Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Phase II Study of Efficacy of Regorafenib as Maintenance Treatment in Patients With High Grade Bone Sarcomas at Diagnosis or Relapse and Without Complete Remission After Standard Treatment

NCT04698785 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04698785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04698785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Phase II Study of Efficacy of Regorafenib as Maintenance Treatment in Patients With High Grade Bone Sarcomas at Diagnosis or Relapse and Without Complete Remission After Standard Treatment
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Recruiting
Start date
July 21, 2021
Completion date
July 21, 2026
Enrollment
36 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

bone sarcoma, osteosarcoma